Current evidence indicates that BSP enhances breast and prostate cancer cell survival through RGD-integrin MEK/ERK signalling and facilitates anoikis resistance in lung cancer via miR-150-5p/MMP-14, ultimately supporting metastatic colonisation. Here, MMP14 is linked to lung carcinoma.